Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Correlation between postoperative prostate-specific antigen and biochemical recurrence in positive surgical margin patients: Single surgeon series.

Seo WI, Kang PM, Yoon JH, Kim W, Chung JI.

Prostate Int. 2017 Jun;5(2):53-58. doi: 10.1016/j.prnil.2017.02.002. Epub 2017 Mar 3.

2.

Laparoscopic radical prostatectomy outcome data: how should surgeon's performance be reported? A retrospective learning curve analysis of two surgeons.

Mason S, Van Hemelrijck M, Chandra A, Brown C, Cahill D.

Ecancermedicalscience. 2016 Jul 6;10:651. doi: 10.3332/ecancer.2016.651. eCollection 2016.

3.

Saudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancer.

Abusamra A, Murshid E, Kushi H, Alkhateeb S, Al-Mansour M, Saadeddin A, Rabah D, Bazarbashi S, Alotaibi M, Alghamdi A, Alghamdi K, Alsharm A, Ahmad I.

Urol Ann. 2016 Apr-Jun;8(2):123-30. doi: 10.4103/0974-7796.176872. Review.

4.

The comparative oncologic effectiveness of available management strategies for clinically localized prostate cancer.

Tyson MD, Penson DF, Resnick MJ.

Urol Oncol. 2017 Feb;35(2):51-58. doi: 10.1016/j.urolonc.2016.03.021. Epub 2016 Apr 28. Review.

PMID:
27133953
5.

Are you now a good surgeon? T2 positive margin status as a quality outcome measure following radical prostatectomy.

Damani A, Van Hemelrijck M, Wulaningsih W, Crawley D, Cahill D.

World J Urol. 2017 Jan;35(1):35-43. doi: 10.1007/s00345-016-1836-0. Epub 2016 Apr 25.

6.

Effect of radical prostatectomy surgeon volume on complication rates from a large population-based cohort.

Almatar A, Wallis CJ, Herschorn S, Saskin R, Kulkarni GS, Kodama RT, Nam RK.

Can Urol Assoc J. 2016 Jan-Feb;10(1-2):45-9. doi: 10.5489/cuaj.3214.

7.

Robotic radical prostatectomy in high-risk prostate cancer: current perspectives.

Canda AE, Balbay MD.

Asian J Androl. 2015 Nov-Dec;17(6):908-15; discussion 913. doi: 10.4103/1008-682X.153541. Review.

8.

Transition from open to robotic-assisted radical prostatectomy is associated with a reduction of positive surgical margins amongst private-practice-based urologists.

Madeb R, Golijanin D, Knopf J, Nicholson C, Cramer S, Tonetti F, Piccone K, Valvo JR, Eichel L.

J Robot Surg. 2007;1(2):145-9. doi: 10.1007/s11701-007-0017-y. Epub 2007 Feb 23.

9.

Significance and management of positive surgical margins at the time of radical prostatectomy.

Silberstein JL, Eastham JA.

Indian J Urol. 2014 Oct;30(4):423-8. doi: 10.4103/0970-1591.134240.

10.

Saudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancer.

Alkhateeb S, Abusamra A, Rabah D, Alotaibi M, Mahmood R, Almansour M, Murshid E, Alsharm A, Alolayan A, Ahmad I, Alkushi H, Alghamdi A, Bazarbashi S.

Urol Ann. 2014 Oct;6(4):278-85. doi: 10.4103/0974-7796.140959.

11.

The impact of fellowship training on pathological outcomes following radical prostatectomy: a population based analysis.

Nayak JG, Drachenberg DE, Mau E, Suderman D, Bucher O, Lambert P, Quon H.

BMC Urol. 2014 Oct 23;14:82. doi: 10.1186/1471-2490-14-82.

12.

Risk Factors for Intraprostatic Incision into Malignant Glands at Radical Prostatectomy.

Park SW, Readal N, Jeong BC, Humphreys EB, Epstein JI, Partin AW, Han M.

Eur Urol. 2015 Aug;68(2):311-6. doi: 10.1016/j.eururo.2014.07.012. Epub 2014 Jul 31.

13.

Disease-specific outcomes of radical prostatectomies in Northern Norway; a case for the impact of perineural infiltration and postoperative PSA-doubling time.

Andersen S, Richardsen E, Nordby Y, Ness N, Størkersen O, Al-Shibli K, Donnem T, Bertilsson H, Busund LT, Angelsen A, Bremnes RM.

BMC Urol. 2014 Jun 14;14:49. doi: 10.1186/1471-2490-14-49.

14.

Positive surgical margins at radical prostatectomy: Population-based averages within PSA and Gleason strata.

Izard JP, Salazar MA, Chatterjee S, Lin DW, Wright JL.

Can Urol Assoc J. 2013 Sep-Oct;7(9-10):E561-6. doi: 10.5489/cuaj.315.

15.

A systematic review of the volume-outcome relationship for radical prostatectomy.

Trinh QD, Bjartell A, Freedland SJ, Hollenbeck BK, Hu JC, Shariat SF, Sun M, Vickers AJ.

Eur Urol. 2013 Nov;64(5):786-98. doi: 10.1016/j.eururo.2013.04.012. Epub 2013 Apr 19. Review.

16.

Quantitative, spectrally-resolved intraoperative fluorescence imaging.

Valdés PA, Leblond F, Jacobs VL, Wilson BC, Paulsen KD, Roberts DW.

Sci Rep. 2012;2:798. doi: 10.1038/srep00798. Epub 2012 Nov 12.

17.

Radical prostatectomy versus observation for localized prostate cancer.

Wilt TJ, Brawer MK, Jones KM, Barry MJ, Aronson WJ, Fox S, Gingrich JR, Wei JT, Gilhooly P, Grob BM, Nsouli I, Iyer P, Cartagena R, Snider G, Roehrborn C, Sharifi R, Blank W, Pandya P, Andriole GL, Culkin D, Wheeler T; Prostate Cancer Intervention versus Observation Trial (PIVOT) Study Group.

N Engl J Med. 2012 Jul 19;367(3):203-13. doi: 10.1056/NEJMoa1113162. Erratum in: N Engl J Med. 2012 Aug 9;367(6):582.

18.

Impact of surgical margin status on prostate-cancer-specific mortality.

Chalfin HJ, Dinizo M, Trock BJ, Feng Z, Partin AW, Walsh PC, Humphreys E, Han M.

BJU Int. 2012 Dec;110(11):1684-9. doi: 10.1111/j.1464-410X.2012.11371.x. Epub 2012 Jul 12.

19.

Variations in the quality of care at radical prostatectomy.

Trinh QD, Sammon J, Jhaveri J, Sun M, Ghani KR, Schmitges J, Jeong W, Peabody JO, Karakiewicz PI, Menon M.

Ther Adv Urol. 2012 Apr;4(2):61-75. doi: 10.1177/1756287211433187.

20.

Frequency of positive surgical margin at prostatectomy and its effect on patient outcome.

Iczkowski KA, Lucia MS.

Prostate Cancer. 2011;2011:673021. doi: 10.1155/2011/673021. Epub 2011 Jun 9.

Supplemental Content

Support Center